Business Wire
11 Jun 2026, 17:33 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
ADMA Biologics is facing a securities fraud lawsuit following allegations of channel stuffing. — Fraud allegations and channel stuffing claims typically lead to severe loss of investor trust and potential regulatory penalties.
-0.80The company's stock price dropped 16% following the channel stuffing claims. — A double-digit price drop confirms immediate negative market sentiment and loss of market capitalization.
-0.50Which stocks this story touches
The company is being sued for securities fraud following allegations of channel stuffing and a significant stock price drop.
Continue reading
6 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
12h ago
